MedPath

Erandamuladi Niruha Basti and Madhutailik Basti in the Management of Polycistic Ovarian Syndrome in the Reproductive age women.

Phase 3
Conditions
Health Condition 1: E282- Polycystic ovarian syndromeHealth Condition 2: E282- Polycystic ovarian syndrome
Registration Number
CTRI/2023/05/052924
Lead Sponsor
SANDHYA MADHUKAR YENNAWAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed cases ofPCOS (by Rotterdam criteria)- Any 2/3.

a. Hyperandrogenism (Clinical or biochemical).

b. Oligomenorrhea (menstrual cycle >35 days)/ Secondary amenorrhea

(menstrual cycle >90 days but < 180 days).

c. USG findings- PCO features on USG i.e. peripherally Arranged Antral Follicle Count >12 with thickened stroma in ovaries and/or Ovarian volume >10 cm 3 in Unilateral or Bilateral ovaries.

Patient fit for basti.

Exclusion Criteria

A. Patient of age group <18 and >35years.

B. Patients showing sign & symptoms other than PCOS.

C. Patient having any other disease causing oligomenorrhea and anovulation excluding PCOS on above criteria i.e.Hypogonadotrophic hypogonadism, premature ovarian failure.

D. Known cases of

a) Congenital adrenal hyperplasia

b) Severe insulin resistance (insulin dependent diabetes mellitus)

c) Androgen secreting ovarian and adrenal tumors d) Thyroid abnormalities

e) Cushing syndrome

f) Cardiac disease

g) Hyperprolactinemia.

E. Patient with any organic lesions of reproductive tract like TB, CA,

Congenital anomalies, any other pelvic pathologies.

F. A current or previous (within 3 months) use of OC Pills, glucocorticoids, antiandrogens, antidiabetics, anti-obesity drugs or any

hormonal therapy.

G. Pregnant patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Follicular growth (Ovulation)Timepoint: Baseline - 4 weeks, 8 weeks and 12 weeks
Secondary Outcome Measures
NameTimeMethod
Hirsutism, Acne, Obesity (BMI), Hormonal estimationTimepoint: Baseline - 4 weeks, 8 weeks and 12 weeks
© Copyright 2025. All Rights Reserved by MedPath